Causes & Types of Constipation

Constipation is classified by the Rome IV criteria as 2 or more of the following for at least 25% of defecations over 3+ months: straining, lumpy or hard stools, sensation of incomplete evacuation, sensation of anorectal obstruction, manual maneuvers, and fewer than 3 spontaneous bowel movements per week.

Primary (functional) constipation types:

  • Normal transit constipation: Most common; stool moves through the colon at normal speed but is perceived as constipated; often due to dietary fiber or fluid insufficiency
  • Slow transit constipation: Reduced colonic motility; stool remains in the colon longer; more common in women; responds less well to fiber alone
  • Defecatory disorders (pelvic floor dysfunction): Inability to coordinate pelvic floor muscles during defecation; requires biofeedback therapy rather than laxatives

Secondary causes to exclude:

  • Hypothyroidism (very common — always test TSH in chronic constipation)
  • Diabetes (autonomic neuropathy affecting gut motility)
  • Medications: Opioids (most common drug cause), iron supplements, calcium channel blockers, anticholinergics, antidepressants
  • Colorectal cancer (red flag — especially new onset with other alarm symptoms)
  • Parkinson disease, multiple sclerosis (neurological causes)
  • Hypercalcemia, hypokalemia (electrolyte disturbances)

Dietary Fiber: The Evidence

Fiber is the most evidence-supported dietary intervention for constipation — but fiber type matters significantly:

  • Soluble fiber (psyllium husk): Strongest evidence for constipation; forms a gel that retains water, softens stool, and increases bulk; 10g/day increases stool frequency and consistency; preferred in both constipation and IBS-C; less gas than insoluble fiber
  • Insoluble fiber (wheat bran, cellulose): Adds bulk and accelerates colonic transit; effective for mild constipation but can worsen bloating and gas; less useful in slow-transit constipation or IBS
  • Kiwifruit: Surprisingly strong evidence — 2 kiwifruit/day shown equivalent to psyllium for improving stool frequency and consistency in multiple RCTs; contains actinidin enzyme and unique fiber composition; practical, palatable option
  • Prunes/dried plums: Well-studied; contain sorbitol (osmotic effect) and fiber; 50g/day (about 5 prunes) shown superior to psyllium in one head-to-head trial for increasing stool frequency
  • Recommended intake: 25–38g total fiber/day (most adults consume only 15g); increase gradually to avoid gas and bloating; always increase fluid intake alongside fiber
  • Resistant starch: Fermented by gut bacteria to produce SCFAs; supports microbiome and motility; found in cooled cooked potatoes, green bananas, legumes

Hydration & Physical Activity

  • Hydration: Adequate fluid intake is essential for fiber to function — fiber absorbs water to soften stool; insufficient fluid with high fiber intake can worsen constipation; target 1.5–2.5L/day total fluid; plain water most effective; coffee has a mild laxative effect via stimulation of colonic motility
  • Exercise and movement: Physical activity stimulates colonic peristalsis via the gastrocolic reflex and autonomic nervous system; sedentary lifestyle is independently associated with constipation; 30 min of brisk walking daily significantly improves bowel frequency in chronic constipation
  • Toilet posture: The squatting position (knees above hips) straightens the anorectal angle and significantly reduces straining; a footstool (15–20 cm) to raise feet while seated on a standard toilet approximates this position; multiple studies confirm reduced evacuation time and straining
  • Bowel routine: Establishing a consistent toilet time — ideally 20–30 minutes after breakfast when the gastrocolic reflex is strongest — trains the bowel and improves regularity

Probiotic Evidence for Constipation

  • Overall evidence: A 2014 meta-analysis of 14 RCTs found probiotics increased stool frequency by 1.3 times per week and reduced gut transit time by 12.4 hours versus placebo
  • Best-evidenced strains: Bifidobacterium lactis (BB-12, HN019) — most consistent evidence for increasing stool frequency; B. longum — multiple trials showing transit time reduction; Lactobacillus casei Shirota — reduces hard stools; multi-strain formulations often superior to single-strain
  • Mechanism: Probiotics increase SCFA production (stimulating gut motility), modulate the enteric nervous system, and reduce intestinal transit time
  • Effect size: Moderate — probiotics should be considered adjunctive to dietary intervention, not a replacement for fiber and hydration
  • Prebiotics: Inulin and FOS selectively feed beneficial bacteria and can improve stool frequency; available as supplements or found in chicory, garlic, onions, asparagus

Laxative Options: Evidence Summary

When dietary and lifestyle measures are insufficient:

  • Osmotic laxatives (PEG/polyethylene glycol — MiraLAX): Draw water into the colon; the most evidence-based pharmacological option for chronic constipation; superior to lactulose in RCTs; safe for long-term use; does not cause dependency or electrolyte disturbance at standard doses
  • Lactulose: Osmotic laxative; effective but produces more gas and bloating than PEG; used in hepatic encephalopathy as primary indication
  • Stimulant laxatives (senna, bisacodyl): Stimulate intestinal smooth muscle; effective for short-term use; use sparingly — concerns about dependency and colonic nerve damage with very long-term use (though evidence is limited); useful for opioid-induced constipation
  • Lubiprostone (Amitiza): Secretagogue activating chloride channels; FDA-approved for chronic idiopathic constipation and IBS-C; increases intestinal fluid secretion
  • Linaclotide (Linzess): Guanylate cyclase-C agonist; promotes intestinal secretion and motility; strong RCT evidence for CIC and IBS-C; reduces abdominal pain
  • Biofeedback therapy: First-line for defecatory disorders (pelvic floor dyssynergia); teaches coordinated relaxation of pelvic floor during defecation; 70–80% success rates — superior to laxatives for this subtype

Red Flags Requiring Medical Evaluation

The following symptoms alongside constipation require prompt medical evaluation to rule out colorectal cancer and other serious conditions:

  • Rectal bleeding or blood in stool
  • Unexplained weight loss
  • New onset constipation after age 50, particularly with no previous bowel symptoms
  • Abdominal mass felt on examination
  • Family history of colorectal cancer or IBD
  • Iron deficiency anemia with bowel symptoms
  • Alternating constipation and diarrhea (may indicate IBS or bowel pathology)
  • Constipation unresponsive to 3–6 months of standard treatment

All adults should follow colorectal cancer screening guidelines — colonoscopy or FIT (fecal immunochemical test) starting at age 45 per current guidelines.

Frequently Asked Questions

The recommended daily fiber intake is 25g for women and 38g for men (most adults consume only 15g). For constipation specifically, soluble fiber from psyllium husk (10g/day) has the strongest evidence. Increase fiber gradually over 2–4 weeks to minimize gas and bloating, and always increase fluid intake simultaneously — fiber requires water to work effectively.

Adequate hydration is essential for fiber to function and stool to soften, but drinking extra water above adequate levels does not produce significant additional benefit in well-hydrated individuals. The combination of adequate fluid (1.5–2.5L/day) with sufficient dietary fiber is most effective. Coffee has a modest laxative effect via stimulation of colonic motility and can be helpful for some people.

Osmotic laxatives (PEG/MiraLAX) are safe for long-term regular use without dependency or electrolyte problems at standard doses. Stimulant laxatives (senna, bisacodyl) are effective short-term but should not be used daily long-term without medical supervision due to concerns about dependency and colonic changes. Fiber supplements (psyllium) are safe indefinitely and are generally preferred.

Yes — multiple meta-analyses confirm probiotics modestly but significantly increase stool frequency (by approximately 1.3 stools per week) and reduce gut transit time. Bifidobacterium strains (B. lactis BB-12, B. longum) have the most consistent evidence. Probiotics are best used as an adjunct to dietary fiber and hydration, not as a standalone treatment.

Seek medical evaluation if you have blood in the stool, unexplained weight loss, new onset constipation after age 50, a palpable abdominal mass, iron deficiency anemia, or constipation unresponsive to 3–6 months of dietary and lifestyle measures. These symptoms require investigation to rule out colorectal cancer and other serious conditions.

Research Summary

Chronic constipation is highly manageable through dietary fiber, hydration, and movement. Psyllium, kiwifruit, and prunes have the strongest dietary evidence; PEG is the most evidence-based laxative for refractory cases.

  • Evidence strength: Strong (4/5)
  • Prevalence: 14–16% of adults globally
  • Best dietary intervention: Psyllium husk 10g/day + 1.5–2.5L fluid/day
  • Practical alternatives: 2 kiwifruit/day or 50g prunes/day — RCT-supported
  • Best laxative: PEG (MiraLAX) — safe for long-term use
  • Always investigate: Blood in stool, weight loss, new onset age 50+
⚠️ Medical Disclaimer: This content is for informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making health decisions.

References

All studies cited are peer-reviewed. DOI and PubMed links open in a new tab.

  1. 1. Bharucha AE, Dorn SD, Lembo A, Pressman A (2013). American Gastroenterological Association Medical Position Statement on Constipation. Gastroenterology, 144(1), 211–217. doi:10.1053/j.gastro.2012.10.029 PMID:23261064
  2. 2. Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K (2014). The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition, 100(4), 1075–1084. doi:10.3945/ajcn.114.089151 PMID:25099542
  3. 3. Rao SS, Rattanakovit K, Patcharatrakul T (2016). Diagnosis and management of chronic constipation in adults. Nature Reviews Gastroenterology & Hepatology, 13(5), 295–305. doi:10.1038/nrgastro.2016.53 PMID:27033126
  4. 4. Chey SW, Chey WD, Jackson K, Eswaran S (2021). Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes in US Patients With Chronic Constipation. American Journal of Gastroenterology, 116(6), 1304–1312. doi:10.14309/ajg.0000000000001149 PMID:33657016
  5. 5. Chapman RW, Stanghellini V, Geraint M, Halphen M (2013). Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with hard stools. American Journal of Gastroenterology, 108(9), 1508–1515. doi:10.1038/ajg.2013.197 PMID:23835437
  6. 6. Tantawy SA, Kamel DM, Abd-alaziem HHE, et al. (2017). Effect of a Proposed Physical Activity and Dietary Control to Manage Constipation in Middle-Aged Obese Women. Diabetes, Metabolic Syndrome and Obesity, 10, 513–519. doi:10.2147/DMSO.S140250 PMID:29290692
  7. 7. Bliss DZ, Savik K, Jung HJ, Whitebird R, Lowry A (2014). Dietary fiber supplementation for fecal incontinence: a randomized clinical trial. Research in Nursing & Health, 37(5), 367–378. doi:10.1002/nur.21616 PMID:25155992
  8. 8. Rao SS, Seaton K, Miller MJ, et al. (2004). Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation. Journal of Psychosomatic Research, 56(3), 341–347. doi:10.1016/S0022-3999(03)00609-1 PMID:15046968